CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Cash flows from operating activities:
Net loss	$ (4,923,223)	$ (886,877)	[1]
Adjustments to reconcile net loss to net cash flows used in operating activities:
Depreciation	734
Amortization of debt discounts and deferred financing	758,490
Change in derivative liabilities	1,214,860
Settlement of legal fees through the issuance of convertible notes	25,000
Changes in operating assets and liabilities:
Prepaid assets	(266,510)
Deferred offering costs	38,500	(38,500)
Accounts payable and accrued expenses	545,442	166,132
Accrued salaries, member	140,591	193,221
Other liabilities	10,000
Contingent liabilities		404,027
Net cash used in operating activities	(2,456,116)	(161,997)
Cash flows from investing activities:
Cash received in reverse merger	209,392
Net cash provided by investing activities	209,392
Cash flows from financing activities:
Cash paid for debt issuance costs	(295,150)
Proceeds from issuing convertible notes	3,934,995
Proceeds from demand note	50,000
Proceeds from participation notes	20,000	125,000
Contribution	2,757
Net cash provided by financing activities	3,712,602	125,000
Net increase (decrease) in cash	1,465,878	(36,997)
Cash, beginning of period	2,523	39,520
Cash, end of period	1,468,401	2,523
Supplemental disclosures of cash flow information:
Interest paid
Income taxes paid
Non-cash investing and financing activities:
Shares issued in reverse merger, net of cash received	1,388,550
Conversion of Series A Preferred stock to common stock	14,000
Warrants issued for deferred financing costs	$ 1,120,970

[1] MV Patents, LLC